Showing results (2101-2110 of 2,632) with videos related to
Sort By:
Pageof 264
Journal of Oncology|October 27, 2022
Cancer Progression Mediated by CAFs Relating to HCC and Identification of Genetic Characteristics Influencing PrognosisLi Song, Qiankun Li, Yao Lu, et al.Journal of Oncology|October 27, 2022
Cellular Landscaping of COVID-19 and Gynaecological Cancers: An Infrequent CorrelationRahul Bhattacharjee, Debanjan Das, Radheka Bhadhuri, et al.Journal of Oncology|October 28, 2022
TRPV1 Is a Potential Tumor Suppressor for Its Negative Association with Tumor Proliferation and Positive Association with Antitumor Immune Responses in Pan-CancerRongfang Nie, Qian Liu, Xiaosheng WangJournal of Oncology|October 28, 2022
Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical CancerYujing Shi, Qing Gao, Zeyuan Liu, et al.Journal of Oncology|October 26, 2022
Exploration of Site-Specific Drug Targeting-A Review on EPR-, Stimuli-, Chemical-, and Receptor-Based Approaches as Potential Drug Targeting Methods in Cancer TreatmentMd Shamiul Islam Rasel, Farhana Afrin Mohona, Wahida Akter, et al.Journal of Oncology|October 26, 2022
Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung AdenocarcinomaHui Zhang, Jin Yuan, Yuehua Xiang, et al.Journal of Oncology|October 26, 2022
GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung AdenocarcinomaYunsong Peng, Zeng Wang, Jianyong Cai, et al.Journal of Oncology|October 6, 2022
Exploration of the Potential Link, Hub Genes, and Potential Drugs for Coronavirus Disease 2019 and Lung Cancer Based on Bioinformatics AnalysisYe Wang, Qing Li, Jianfang Zhang, et al.Journal of Oncology|October 6, 2022
Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World StudyJingjing Qu, Farhin Shaheed Kalyani, Qian Shen, et al.Journal of Oncology|October 6, 2022
Survival Outcomes of Patients with Follicular Lymphoma after Relapse or Progression: A Single-Center Real-World Data AnalysisYong-Pyo Lee, Min-Sang Lee, Sang Eun Yoon, et al.Pageof 264